Synapse - Works

Results (117469)

Induction with bortezomib and dexamethasone (BD) followed by risk adapted high dose melphalan and autologous stem cell transplantation and BD consolidation in patients with AL amyloidosis: A phase II feasibility study

Meeting Abstract

Landau, H.; Montanez, N.; Cowan, A.; Hoover, E.; Flombaum, C.; Liu, J.; Maurer, M.; Lendvai, N.; Landgren, O.; Giralt, S. A.; more...
Blood (2015)

Fulltext@MSK | Save

A role for IL1RAP in acute myelogenous leukemia stem cells following treatment and progression

Meeting Abstract

Ho, T. C.; Jordan, C. T.; LaMere, M. W.; Ashton, J. M.; O'Dwyer, K.; Mendler, J. H.; Liesveld, J. L.; Wang, E. S.; Guzman, M. L.; Calvi, L. M.; more...
Blood (2015)

Fulltext@MSK | Save

AUY922, a Heat Shock Protein 90 (Hsp90) inhibitor, demonstrates activity in patients with myeloproliferative neoplasms (MPNs)

Meeting Abstract

Hobbs, G.; Litvin, R.; Ahn, J.; McKenney, A. S.; Mauro, M. J.; Tallman, M. S.; Berman, E.; Heaney, M. L.; Levine, R. L.; Rampal, R. K.
Blood (2015)

Fulltext@MSK | Save

Erwinia asparaginase safety and feasibility during therapy for acute lymphoblastic leukemia in adult patients with pegaspargase hypersensitivity or severe toxicity

Meeting Abstract

Horvat, T. Z.; Pecoraro, J. J.; Daley, R. J.; Buie, L. W.; Douer, D.
Blood (2015)

Fulltext@MSK | Save

Infection burden of double stranded DNA (dsDNA) viruses after CD34(+) selected, T-cell depleted (TCD) hematopoietic cell transplantation (HCT) for myeloid malignancies at Memorial Sloan Kettering Cancer Center (MSK)

Meeting Abstract

Huang, Y. T. H.; Kim, S. J.; Lee, Y. J.; Burack, D.; Nichols, P.; Maloy, M.; Tamari, R.; Perales, M. A.; Giralt, S. A.; Castro-Malaspina, H. R.; more...
Blood (2015)

Fulltext@MSK | Save

Phase 1 trial of targeted alpha-particle immunotherapy with actinium-225 ((225)Ac)-lintuzumab (Anti-CD33) and low-dose cytarabine (LDAC) in older patients with untreated acute myeloid leukemia (AML)

Meeting Abstract

Jurcic, J. G.; Ravandi, F.; Pagel, J. M.; Park, J. H.; Smith, B. D.; Levy, M. Y.; Estey, E. H.; Perl, A. E.; Kantarjian, H.; Earle, D.; more...
Blood (2015)

Fulltext@MSK | Save

Defibrotide for the treatment of patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome with/without multi-organ dysfunction following chemotherapy: Results from an ongoing expanded access program

Meeting Abstract

Kernan, N. A.; Richardson, P. G.; Smith, A. R.; Triplett, B. M.; Grupp, S. A.; Antin, J. H.; Lehmann, L. E.; Liang, W.; Hume, R. L.; Hannah, A. L.; more...
Blood (2015)

Fulltext@MSK | Save

Pooled treatment analysis of pediatric patients with defibrotide for hepatic veno-occlusive disease/sinusoidal obstruction syndrome and multi-organ dysfunction following hematopoietic stem cell transplant

Meeting Abstract

Kernan, N. A.; Grupp, S. A.; Banerjee, K.; Hannah, A. L.; Hume, R. L.; Nejadnik, B.; Richardson, P.
Blood (2015)

Fulltext@MSK | Save

T-cell depleted peripheral blood stem cell (TCD-PBSC) transplants secure consistent engraftment with low risk of acute or chronic Gvhd and favorable disease free survival (DFS) and overall survival (OS) for pediatric patients (<21 years) with AML in CR1 or CR2 or MDS including tMDS/AML

Meeting Abstract

Kernan, N. A.; Boulad, F.; Prockop, S.; Wolden, S.; Scaradavou, A.; Kobos, R.; Lehrman, R.; Klein, E.; Curran, K. J.; Hasan, A. N.; more...
Blood (2015)

Fulltext@MSK | Save

Mir-99 is a regulator of hematopoietic and leukemic stem cell differentiation

Meeting Abstract

Khalaj, M.; Hu, W.; Park, C. Y.
Blood (2015)

Fulltext@MSK | Save